Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
GFR Decline as an Alternative End Point in...
Journal article

GFR Decline as an Alternative End Point in Clinical Trials to Prevent ESRD: Are We Increasing Treatment Uncertainty for the Sake of Feasibility?

Authors

Sontrop JM; Al-Jaishi AA; Garg AX

Journal

American Journal of Kidney Diseases, Vol. 64, No. 6, pp. 841–844

Publisher

Elsevier

Publication Date

12 2014

DOI

10.1053/j.ajkd.2014.10.002

ISSN

0272-6386